TuHURA Biosciences (HURA) Free Cash Flow (2010 - 2026)

TuHURA Biosciences' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$4.5 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 4.39% year-over-year to -$4.5 million in Q1 2026; TTM through Mar 2026 was -$27.3 million, a 5.85% decrease from a year earlier, with the FY2025 full-year figure at -$27.5 million, down 87.9% from the prior year.
• Free Cash Flow grew to -$4.5 million in Q1 2026 per HURA's latest filing, from -$5.3 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $3.5 million in Q2 2023 and bottomed at -$12.3 million in Q3 2024.
• The 5-year median for Free Cash Flow is -$5.3 million (2025), against an average of -$5.4 million.
• Across the five-year window, Free Cash Flow surged 80.05% in 2023 and slumped 832.56% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at -$7.2 million in 2022, then surged by 52.11% to -$3.5 million in 2023, then sank by 255.58% to -$12.3 million in 2024, then surged by 56.49% to -$5.3 million in 2025, then gained by 16.5% to -$4.5 million in 2026.
• Per Business Quant, the three latest HURA Free Cash Flow figures stand at -$4.5 million (Q1 2026), -$5.3 million (Q4 2025), and -$11.1 million (Q3 2025).